Hints and tips:
...Maybe we will discover that many managers were smart enough to sell out of Apple, Valeant, Williams et al before their shares tanked....
...But when the firms sold Nycomed to Takeda Pharmaceutical for $13.7bn last year, they kept Fougera....
...One possibility could be selling the division to Takeda Pharmaceutical, Japan’s largest drugmaker. Solvay and Sanofi declined to comment, while a spokesman for Solvac was unavailable....
...So far, only Novartis of Switzerland has adopted such a model on any scale, consolidating its long-standing Sandoz division with the purchase of Hexal of Germany in 2006 to create the world’s second-largest...
International Edition